Search results for: 'Antibody-Drug Conjugate Contract Development and Manufacturing Organization'

28 Jun 2018  |  North America  |  Market Research

North American Energy Saving and Performance Contracting Market, Forecast to 2024

HVAC and Lighting Will Be the Primary Pillars of the Market by 2024

Infographics

×

Key Issues Addressed

The North American energy saving and performance contracting market is currently in the growth stage and is expected to witness healthy growth between 2017 and 2024. The market is expected to grow at a CAGR of 7.34% between 2017 and 2024. A high rate of growth is due to the government support and policy initiatives toward energy performance contrac...

The treatment of rare diseases requires the use of specialized drugs. Patient populations for rare diseases are most often quite small, consequently the products treating them earn the designation orphan drugs. These drugs must undergo the research, development, and clinical trials that all drugs do, yet the investment into the development is great...

01 Mar 2024  |  North America  |  Market Research

Global Orphan Drug Growth Opportunities

Reduced Exclusivity and Increased Competition will Drive Demand for More Efficient R&D and Digital Solutions

Infographics

×

In this study, Frost & Sullivan s Transformational Health team provides critical insights into the global orphan drug (OD) industry and highlights growth opportunities, revenue, regulatory changes, and technology trends influencing growth. Approximately 5% of rare diseases (RDs) have received US FDA approval for a drug, while up to 15% of RDs have ...

With the healthcare industry moving toward patient convenience and comfort, pharmaceutical and medical device companies are continuously researching for the most effective, side effect free, convenient route of drug delivery. Transdermal drug delivery is a painless method of delivering drug formulation. Transdermal route of drug administration has ...

Automotive sales in 2021 continued the seismic shift to electric vehicles (EV) that began in 2020, defying even the most bullish estimates as global EV sales grew by more than 100% year over year (YoY) with close to 6.7 million units sold to achieve 8.9% penetration in the passenger car market. China and Europe led the way, closely followed by the ...

29 Sep 2023  |  North America  |  Market Research

Competitive Analysis of Original Equipment Manufacturer (OEM) Investments in Vehicle Electrification

Localized Battery Development and Production Prioritized to Cater to Future Regional Electric Vehicle (EV) Demand

Infographics

×

Frost & Sullivan’s projection indicates that the global EV market will record over 44% year-on-year unit sales growth in 2023. China, Europe, and North America will be important contributors to this surge. Increased focus on reducing carbon emissions will drive EV demand in coming years. OEMs have been rushing to gain a share of the competitive EV ...

Buildings are becoming more energy-intensive and with features like electric vehicle charging adding to the existing load, the need to reduce energy consumption acquires an even greater importance. Energy saving and performance contracting (ESPC) is one way to achieve energy efficiency. In that sense, North America has been the second-largest marke...

Tissue engineering, which is now being categorized as a form of regenerative medicine, can be defined as biomedical engineering to reconstruct, repair, and improve biological tissues. Research efforts in tissue engineering have been ongoing and it is emerging as one of the key areas of medical research. Furthermore, there are vast developments in t...

Excipients are used to support the delivery of the APIs (active pharmaceutical ingredients) through oral dosage, parenteral, and transdermal medications. For oral dosages, the key delivery forms are tablets and capsules. This research service covers the North American oral solid drug dosage excipients market. Based on functionality, excipients are ...